When AncestryDNA sold some 1.5 million of its genetic testing kits over Black Friday weekend, it seemed like clear evidence that after years of being a niche product, consumer DNA testing had finely gone mainstream. The market is expected to keep booming. A new report out from market research firm Kalorama Information estimates that the consumer market for genetic health testing alone could nearly triple from about $99 million this past year to $310 million in 2022. That’s an awful lot of spit.
The report suggests the the reason for this growth is that consumers are interested in taking control of their health care, and regulations are finally allowing them to do so.
Initially, the FDA banned DNA testing companies from telling people whether or not they’re are at risk for certain diseases, a move that forced 23andMe to go through a long and presumably painful process to prove that its tests are accurate.
Recently, some have begun calling on the Federal Trade Commission to take a similarly critical eye to DNA testing companies.
What’s certain is that more people than ever are interested in finding out what their genes have to say about them. And as consumer genetic testing moves beyond the niche, the importance of addressing these concerns grows, too.
Read full, original post: The Consumer DNA Testing Market Is Already Booming, but It’s About to Explode